Cyclacel Pharmaceuticals (CYCCP) Announces Positive Interim Data From Phase 2 Trials of Oral Seliciclib
Tweet Send to a Friend
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) announced interim data from the lead-in stage of a Phase 2 randomized clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
